ForeverLabs
ServicesProvidersScienceMission
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Stroke
AI generated image for: Stem Cell–Based Immunomodulation After Stroke: Effects on Brain Repair Processes
Clinical
Aug 11, 2025
1 min read
AHA Journals
Stem Cell–Based Immunomodulation After Stroke: Effects on Brain Repair Processes
Stem cell-based approaches can induce poststroke recovery via mechanisms, such as neuronal replacement, promotion of angiogenesis, induction of brain plasticity, reduction of cell death, or immunomodulation.
Stroke recoveryStroke
AI generated image for: Autologous mesenchymal stem cell transplantation in stroke patients
Clinical
Aug 11, 2025
1 min read
Wiley
Autologous mesenchymal stem cell transplantation in stroke patients
Changes in neurological deficits and improvements in function were compared between two groups for 1 year after symptom onset. Patients treated with autologous MSCs showed significant improvement in both cognition and mobility.
Stroke recoveryStroke
AI generated image for: Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials
Clinical
Aug 11, 2025
1 min read
PubMed
Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials
MSC therapy is safe and effective in treating IS by improving the neurological deficits, motor function and daily life quality of patients.
Stroke recoveryStroke

Stay in touch

Shop

Annual planLifetime planClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy policyPressTerms of Use

Questions

For physiciansPartner with usCareersContact us(888) 732-2375
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.